Innovative tech to help people living with diabetes

Loading player...
GUEST – Dr Grant Newton - CEO of the Centre for Diabetes and Endocrinology

Two healthcare companies in the South Africa, 3Sixty Global Solutions Group and the Centre for Diabetes and Endocrinology (CDE) are introducing devices to help people living with diabetes monitor blood sugar levels without injections or needles.

Currently Diabetics must prick their fingers to know if sugar level is too high or too low in their bodies. The companies are getting rid of the painful injections by introducing needle-free devices. This means people living with diabetes will no longer jab themselves to monitor blood sugar levels. This is a milestone, as monitoring sugar in the blood will be painless. One device you have to wear on the arm to monitor the sugar level. The other is a mobile hand held camera to detect complications of diabetes, diseases such as Diabetic retinopathy (complication of diabetes that affects the eyes), Diabetic neuropathy (nerve damage due to diabetes that can affect the legs and feet). This is good news to people living with diabetes because they have been suffering from needle-phobia.
23 Apr 2024 2PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min